BRPI0513267A - variantes melhoradas de aprotinina - Google Patents
variantes melhoradas de aprotininaInfo
- Publication number
- BRPI0513267A BRPI0513267A BRPI0513267-3A BRPI0513267A BRPI0513267A BR PI0513267 A BRPI0513267 A BR PI0513267A BR PI0513267 A BRPI0513267 A BR PI0513267A BR PI0513267 A BRPI0513267 A BR PI0513267A
- Authority
- BR
- Brazil
- Prior art keywords
- improved
- proteins
- field
- relates
- serine protease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8114—Kunitz type inhibitors
- C07K14/8117—Bovine/basic pancreatic trypsin inhibitor (BPTI, aprotinin)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
VARIANTES MELHORADAS DE APROTININA. A presente invenção refere-se ao campo de proteínas que inibem a atividade de serina protease. A invenção também refere-se ao campo de construtos de ácido nucléico, vetores e células hospedeiras para produzir proteínas inibidoras de serina proteases, composições farmacêuticas contendo tais proteínas e métodos para seu uso.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58765504P | 2004-07-13 | 2004-07-13 | |
PCT/US2005/024951 WO2006017355A2 (en) | 2004-07-13 | 2005-07-13 | Improved aprotinin variants |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0513267A true BRPI0513267A (pt) | 2008-05-06 |
Family
ID=35839810
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0513267-3A BRPI0513267A (pt) | 2004-07-13 | 2005-07-13 | variantes melhoradas de aprotinina |
Country Status (15)
Country | Link |
---|---|
US (1) | US20090005297A1 (pt) |
EP (1) | EP1771464A4 (pt) |
JP (1) | JP2008506391A (pt) |
KR (1) | KR20070041749A (pt) |
CN (1) | CN101014611A (pt) |
AU (1) | AU2005271708A1 (pt) |
BR (1) | BRPI0513267A (pt) |
CA (1) | CA2573368A1 (pt) |
EC (1) | ECSP077240A (pt) |
IL (1) | IL180370A0 (pt) |
MA (1) | MA28779B1 (pt) |
MX (1) | MX2007000473A (pt) |
NO (1) | NO20070640L (pt) |
RU (1) | RU2007105137A (pt) |
WO (1) | WO2006017355A2 (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008110301A1 (de) * | 2007-03-13 | 2008-09-18 | Bayer Schering Pharma Aktiengesellschaft | Aprotinin-varianten mit verbesserten eigenschaften |
WO2009030464A2 (de) * | 2007-09-08 | 2009-03-12 | Bayer Schering Pharma Aktiengesellschaft | HERSTELLUNG UND VERWENDUNG VON VARIANTEN HUMANER KUNITZ-TYP PROTEASE-INHIBITOREN (hKTPI) |
CN101412995B (zh) * | 2007-10-17 | 2011-04-06 | 江苏正大天晴药业股份有限公司 | 聚乙二醇修饰的抑肽酶及其制备方法 |
WO2010033226A1 (en) * | 2008-09-17 | 2010-03-25 | Nektar Therapeutics | Oligomer-protease inhibitor conjugates |
WO2010088547A1 (en) * | 2009-01-29 | 2010-08-05 | Bayer Healthcare Llc | Assays for detecting pegylated blood coagulation factors |
DE102011013326A1 (de) | 2011-03-08 | 2012-09-13 | Solution Shop Ag | Neue Fibrinolyse-Inhibitoren und deren mdizinische Verwendung |
JP6195855B2 (ja) * | 2012-03-03 | 2017-09-13 | イミュンジーン,インコーポレーテッド | 工学的に作製した抗体−インターフェロン変異体融合分子 |
US9605057B1 (en) * | 2013-06-17 | 2017-03-28 | Board Of Regents Of The University Of Texas System | Endotrophin neutralization and use thereof |
WO2017098516A1 (en) * | 2015-12-10 | 2017-06-15 | The National Institute for Biotechnology in the Negev Ltd. | VARIANTS OF AMYLOID beta-PROTEIN PRECURSOR INHIBITOR DOMAIN |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69233108T2 (de) * | 1991-03-01 | 2004-04-29 | Dyax Corp., Cambridge | Hemmstoffe für menschliche neutrophile elastase und menschliches kathepsin g |
IL104314A0 (en) * | 1992-01-07 | 1993-05-13 | Novo Nordisk As | Human kunitz-type protease inhibitor and variants thereof,their production and pharmaceutical compositions containing them |
-
2005
- 2005-07-13 MX MX2007000473A patent/MX2007000473A/es unknown
- 2005-07-13 EP EP05791407A patent/EP1771464A4/en not_active Withdrawn
- 2005-07-13 WO PCT/US2005/024951 patent/WO2006017355A2/en active Application Filing
- 2005-07-13 CN CNA2005800302602A patent/CN101014611A/zh active Pending
- 2005-07-13 JP JP2007521627A patent/JP2008506391A/ja not_active Withdrawn
- 2005-07-13 KR KR1020077003345A patent/KR20070041749A/ko not_active Application Discontinuation
- 2005-07-13 CA CA002573368A patent/CA2573368A1/en not_active Abandoned
- 2005-07-13 US US11/659,434 patent/US20090005297A1/en not_active Abandoned
- 2005-07-13 BR BRPI0513267-3A patent/BRPI0513267A/pt not_active IP Right Cessation
- 2005-07-13 AU AU2005271708A patent/AU2005271708A1/en not_active Abandoned
- 2005-07-13 RU RU2007105137/13A patent/RU2007105137A/ru not_active Application Discontinuation
-
2006
- 2006-12-26 IL IL180370A patent/IL180370A0/en unknown
-
2007
- 2007-02-01 MA MA29646A patent/MA28779B1/fr unknown
- 2007-02-05 NO NO20070640A patent/NO20070640L/no not_active Application Discontinuation
- 2007-02-12 EC EC2007007240A patent/ECSP077240A/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU2005271708A1 (en) | 2006-02-16 |
RU2007105137A (ru) | 2008-08-20 |
NO20070640L (no) | 2007-04-11 |
WO2006017355A3 (en) | 2006-12-14 |
EP1771464A2 (en) | 2007-04-11 |
MX2007000473A (es) | 2007-03-29 |
ECSP077240A (es) | 2007-03-29 |
MA28779B1 (fr) | 2007-08-01 |
US20090005297A1 (en) | 2009-01-01 |
WO2006017355A2 (en) | 2006-02-16 |
IL180370A0 (en) | 2007-06-03 |
CA2573368A1 (en) | 2006-02-16 |
KR20070041749A (ko) | 2007-04-19 |
CN101014611A (zh) | 2007-08-08 |
JP2008506391A (ja) | 2008-03-06 |
EP1771464A4 (en) | 2008-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0513267A (pt) | variantes melhoradas de aprotinina | |
Zou et al. | Catalytic activity of human ADAM33 | |
MX2009008925A (es) | Compuestos de la formula (i) como inhibidores de proteasa de serina. | |
BRPI0618654A8 (pt) | variante de zimogênio/protease de fator x/fator xa, ácido nucléico, composição farmacêutica que os contém, vetor, bem como uso dos mesmos | |
Pan et al. | Development of activity-based probes for trypsin-family serine proteases | |
BR0309671A (pt) | ácidos de piperidinil- e piperazinil-sulfonilmetil hidroxâmicos e seu uso como inibidores de protease | |
SE0201980D0 (sv) | Novel compounds | |
ATE530643T1 (de) | Säureaktive fungale protease | |
EA200702568A1 (ru) | Гетеробициклические ингибиторы металлопротеазы и их применение | |
EA200800670A1 (ru) | Ингибиторы сериновых протеаз | |
MX2009013085A (es) | Metodos para mejorar el desempeño de la proteina. | |
MX2010004371A (es) | Proteasa de streptomyces. | |
SE0201976D0 (sv) | Novel compounds | |
ATE420879T1 (de) | Indolizine als kinaseproteinhemmer | |
WO2003066824A3 (en) | Albumin-fused kunitz domain peptides | |
BRPI0517035A (pt) | novos compostos | |
WO2006076246A3 (en) | Phenylglycinamide derivatives useful as anticoagulants | |
ATE501268T1 (de) | Vorrichtungen und verfahren zur bestimmung von proteaseaktivität | |
EA200800357A1 (ru) | Новые фармацевтические соединения | |
BRPI0507613A (pt) | expressão de plasminogênio e microplasminogênio em lentilha d'água | |
SE0201977D0 (sv) | Novel compounds | |
BR0310003A (pt) | compostos peptìdeos e seu uso como substratos de protease | |
ATE309264T1 (de) | Peptidyl-2-amino-1hydroxyalkansulfonsäuren als cystein-protease-inhibitoren | |
NO20055210D0 (no) | Inhibitorproteiner av en protease og anvendelse derav | |
MX9702776A (es) | Proteinas de proteasa de pulgas, moleculas de acido nucleico, y usos de las mismas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A E 6A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |